Genetic Testing in Epilepsy.
David M RitterKatherine HollandPublished in: Seminars in neurology (2020)
Because of next-generation sequencing and the discovery of many new causative genes, genetic testing in epilepsy patients has become widespread. Pathologic variants resulting in epilepsy cause a variety of changes that can be broadly classified into syndromic disorders (i.e., chromosomal abnormalities), metabolic disorders, brain malformations, and abnormal cellular signaling. Here, we review the available genetic testing, reasons to pursue genetic testing, common genetic causes of epilepsy, the data behind what patients are found to have genetic epilepsies based on current testing, and discussing these results with patients. We propose an algorithm for testing patients with epilepsy to maximize yield and limit costs based on their phenotype (including electroencephalography and magnetic resonance imaging findings), age of seizure onset, and presence of other neurologic comorbidities. Being able to discern which type of genetic testing to order, using that information to give targeted and cost-effective patient care, and interpreting results accurately will be a crucial skill for the modern neurologist.
Keyphrases
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- copy number
- prognostic factors
- squamous cell carcinoma
- healthcare
- machine learning
- drug delivery
- multiple sclerosis
- transcription factor
- high throughput
- autism spectrum disorder
- brain injury
- intellectual disability
- resting state
- blood brain barrier
- functional connectivity
- single cell
- contrast enhanced
- neural network
- cell free